Qube Research & Technologies (QRT)’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-49,324
| Closed | -$351K | – | 3065 |
|
2025
Q1 | $351K | Sell |
49,324
-432,243
| -90% | -$3.07M | ﹤0.01% | 2066 |
|
2024
Q4 | $5.62M | Buy |
481,567
+292,634
| +155% | +$3.41M | 0.01% | 1116 |
|
2024
Q3 | $3.88M | Buy |
+188,933
| New | +$3.88M | 0.01% | 1203 |
|
2024
Q2 | – | Sell |
-44,588
| Closed | -$1.23M | – | 3951 |
|
2024
Q1 | $1.23M | Sell |
44,588
-196,103
| -81% | -$5.39M | ﹤0.01% | 1726 |
|
2023
Q4 | $7.34M | Buy |
240,691
+195,432
| +432% | +$5.96M | 0.01% | 715 |
|
2023
Q3 | $1.43M | Sell |
45,259
-24,481
| -35% | -$774K | ﹤0.01% | 1265 |
|
2023
Q2 | $2.84M | Buy |
69,740
+46,774
| +204% | +$1.91M | 0.01% | 835 |
|
2023
Q1 | $856K | Sell |
22,966
-1,869
| -8% | -$69.7K | ﹤0.01% | 1294 |
|
2022
Q4 | $866K | Buy |
+24,835
| New | +$866K | ﹤0.01% | 1215 |
|
2022
Q2 | – | Sell |
-16,572
| Closed | -$1.2M | – | 2916 |
|
2022
Q1 | $1.2M | Buy |
+16,572
| New | +$1.2M | 0.01% | 1052 |
|
2021
Q4 | – | Sell |
-1,652
| Closed | -$222K | – | 2837 |
|
2021
Q3 | $222K | Sell |
1,652
-16,932
| -91% | -$2.28M | ﹤0.01% | 1611 |
|
2021
Q2 | $3.01M | Buy |
+18,584
| New | +$3.01M | 0.03% | 557 |
|